Rare condition

Congenital mitral stenosis

ORPHA:99057 ↗Morphological anomaly

2

studies recruiting now

as of 7 Sept 2026

3

studies registered in total

as of 7 Sept 2026

2

countries with a recruiting site

as of 7 Sept 2026

9 Apr 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNCT06607471

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Sponsor Scientific Institute San RaffaeleWhere Italy (1 site)Studying Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation, Support treatment, cardiac medical treatment, aetiology-specific treatmentUpdated 23 Sept 2024

Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Congenital mitral stenosis studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Congenital mitral stenosis study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Congenital mitral stenosis

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).